These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3874828)

  • 1. Isotype commitment of B cells and dissemination of the primed state after mucosal stimulation with Mycoplasma pulmonis.
    Rose FV; Cebra JJ
    Infect Immun; 1985 Aug; 49(2):428-34. PubMed ID: 3874828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary intratracheal infection of mice with Mycoplasma pulmonis generates IgG1 memory B cells.
    Rose FV; Cebra JJ
    Isr J Med Sci; 1987 May; 23(5):490-5. PubMed ID: 3499421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in specific B cells and the dissemination of the primed state in vivo following antigenic stimulation by different mucosal routes.
    Cebra JJ; Fuhrman JA; Griffin P; Rose FV; Schweitzer PA; Zimmerman D
    Ann Allergy; 1984 Dec; 53(6 Pt 2):541-9. PubMed ID: 6209998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin class- and subclass-specific responses to Mycoplasma pulmonis in sera and secretions of naturally infected Sprague-Dawley female rats.
    Brown MB; Reyes L
    Infect Immun; 1991 Jun; 59(6):2181-5. PubMed ID: 2037378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro stimulation of nonimmunized, naturally infected rat spleen cells for the production of Mycoplasma pulmonis-specific monoclonal antibodies.
    Jarvill KJ; Minion FC
    Hybridoma; 1989 Oct; 8(5):545-50. PubMed ID: 2807312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogenic activity of Mycoplasma pulmonis. I. Stimulation of rat B and T lymphocytes.
    Naot Y; Merchav S; Ben-David E; Ginsburg H
    Immunology; 1979 Mar; 36(3):399-406. PubMed ID: 374251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine respiratory mycoplasmosis: a model to study effects of oxidants.
    Davis JK; Davidson M; Schoeb TR
    Res Rep Health Eff Inst; 1991 Dec; (47):1-29; discussion 31-43. PubMed ID: 1838926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective Fas ligand-mediated apoptosis predisposes to development of a chronic erosive arthritis subsequent to Mycoplasma pulmonis infection.
    Hsu HC; Zhang HG; Song GG; Xie J; Liu D; Yang PA; Fleck M; Wintersberger W; Zhou T; Edwards CK; Mountz JD
    Arthritis Rheum; 2001 Sep; 44(9):2146-59. PubMed ID: 11592380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory properties of Mycoplasma pulmonis. III. Lymphocyte stimulation and cytokine production by Mycoplasma pulmonis products.
    Romero-Rojas A; Reyes-Esparza J; Estrada-Parra S; Hadden JW
    Int Immunopharmacol; 2001 Sep; 1(9-10):1699-707. PubMed ID: 11562062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiated B lymphocytes. Potential to express particular antibody variable and constant regions depends on site of lymphoid tissue and antigen load.
    Gearhart PJ; Cebra JJ
    J Exp Med; 1979 Jan; 149(1):216-27. PubMed ID: 105075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characteristics of Peyer's patch lymphoid cells. II. Lipopolysaccharide is thymus dependent.
    Kagnoff MF; Billings P; Cohn M
    J Exp Med; 1974 Feb; 139(2):407-13. PubMed ID: 4589992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated and humoral immune response to non-viable Mycoplasma pulmonis in mice enhanced by cross-linked ricin.
    Kishima M; Kuniyasu C; Eguchi M; Yamamoto M; Imamura E
    Vet Microbiol; 1987 Jun; 14(2):145-56. PubMed ID: 3660582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyclonal activation of rat splenic lymphocytes after in vivo administration of Mycoplasma pulmonis and its relation to in vitro response.
    Williamson JS; Davis JK; Cassell GH
    Infect Immun; 1986 May; 52(2):594-9. PubMed ID: 3486159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. I. T cells derived from Peyer's patches that switch sIgM B cells to sIgA B cells in vitro.
    Kawanishi H; Saltzman LE; Strober W
    J Exp Med; 1983 Feb; 157(2):433-50. PubMed ID: 6185611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive protein antigens of Mycoplasma pulmonis in experimentally infected rats.
    Chang J; Pick JR
    Am J Vet Res; 1986 Sep; 47(9):1901-4. PubMed ID: 3767096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of mice against Mycoplasma pulmonis infection using purified mouse immunoglobulins: comparison between protective effect and biological properties of immunoglobulin classes.
    Taylor G; Howard CJ
    Immunology; 1981 Jul; 43(3):519-25. PubMed ID: 7251063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycoplasma pulmonis V-1 surface protein variation: occurrence in vivo and association with lung lesions.
    Talkington DF; Fallon MT; Watson HL; Thorp RK; Cassell GH
    Microb Pathog; 1989 Dec; 7(6):429-36. PubMed ID: 2622331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis.
    Mize MT; Sun XL; Simecka JW
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mitogens from Mycoplasma pulmonis and Mycoplasma neurolyticum.
    Katz R; Siman-Tov R; Naot Y
    Yale J Biol Med; 1983; 56(5-6):613-21. PubMed ID: 6332429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of vaccines on Mycoplasma pulmonis-induced respiratory disease of mice.
    Taylor G; Howard CJ; Gourlay RN
    Infect Immun; 1977 May; 16(2):422-31. PubMed ID: 558962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.